People aging with 4 antiretroviral class resistant HIV are a very challenging population. It is difficult to build up a fully suppressive regimen, and the high prevalence of comorbidities and polypharmacy may cause drug-drug interactions and put adherence at risk. We herein present the case of an 80-year-old man, participating in the PRESTIGIO registry, asking for a reduction in his antiretroviral burden while on polypharmacy for his comorbidities.
Mazzitelli, M., Zazzi, M., Marchetti, G., Spagnuolo, V., Santoro, M. M., Foca, E., Cattelan, A., Castagna, A., PRESTIGIO RING: “An 80-year-old man living with HIV resistant to all four antiretroviral classes and desiring treatment simplification”, <<NEW MICROBIOLOGICA>>, 2023; 46 (4): 407-411 [https://hdl.handle.net/10807/338492]
PRESTIGIO RING: “An 80-year-old man living with HIV resistant to all four antiretroviral classes and desiring treatment simplification”
Mazzitelli, Maria
;
2023
Abstract
People aging with 4 antiretroviral class resistant HIV are a very challenging population. It is difficult to build up a fully suppressive regimen, and the high prevalence of comorbidities and polypharmacy may cause drug-drug interactions and put adherence at risk. We herein present the case of an 80-year-old man, participating in the PRESTIGIO registry, asking for a reduction in his antiretroviral burden while on polypharmacy for his comorbidities.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
